Volume 2.42 | Oct 25

Hematopoiesis News 2.42, October 25, 2011
     In this issue: Publications | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Hematopoiesis News on Twitter
TOP STORY
Osteoclasts Are Dispensable for Hematopoietic Stem Cell Maintenance and Mobilization
Osteoclast activity is inversely correlated with hematopoietic activity; however, how osteoclasts and the bone marrow cavity potentially regulate hematopoiesis is not well understood. To investigate this question, scientists evaluated hematopoietic activity in three osteopetrotic mouse models: op/op, c-Fos-deficient, and RANKL (receptor activator of nuclear factor kappa B ligand)-deficient mice [J Exp Med] Abstract


ON199-HAA-ISCT_645x110
PUBLICATIONS (Ranked by Impact Factor of the Journal)
LABORATORY RESEARCH

Polymeric IgA1 Controls Erythroblast Proliferation and Accelerates Erythropoiesis Recovery in Anemia
Scientists show that, when cultured with erythropoietin at suboptimal concentrations, the growth and clonogenic potential of erythroblasts was rescued by transferrin receptor 1-bound polymeric IgA1. [Nat Med] Abstract


The Ability of MLL to Bind RUNX1 and Methylate H3K4 at PU.1 Regulatory Regions Is Impaired by MDS/AML-Associated RUNX1/AML1 Mutations
Investigators have identified a physical and functional interaction between RUNX1 (AML1) and Mixed-Lineage Leukemia (MLL) and show that both are required to maintain the histone lysine 4 trimethyl mark at two critical regulatory regions of the AML1 target gene PU.1. [Blood] Abstract


AML1/RUNX1 Functions as a Cytoplasmic Attenuator of NF-κB Signaling in the Repression of Myeloid Tumors
Here scientists explored immediate target pathways of AML1 by in vitro synchronous inactivation in hematopoietic cells. [Blood] Abstract


Short Telomeres Result in Chromosomal Instability in Hematopoietic Cells and Precede Malignant Evolution in Human Aplastic Anemia
Here researchers directly implicate telomere shortening as a critical molecular event for malignant evolution in aplastic anemia. [Leukemia] Abstract


The Transcriptional Coactivator Cbp Regulates Self-Renewal and Differentiation in Adult Hematopoietic Stem Cells
Here, investigators demonstrate a gradual loss of phenotypic hematopoietic stem cells and differentiation defects following conditional ablation of Cbp during adult homeostasis. [Mol Cell Biol] Abstract


miR-590-5p, miR-219-5p, miR-15b and miR-628-5p Are Commonly Regulated by IL-3, GM-CSF and G-CSF in Acute Myeloid Leukemia
Using real-time PCR-based miRNA expression profiling, scientists investigated miRNA signatures regulated by IL-3, GM-CSF and G-CSF for n = 704 miRNAs. [Leuk Res] Abstract


CLINICAL RESEARCH

No Difference in Outcome Between Children and Adolescents Transplanted for Acute Lymphoblastic Leukemia in Second Remission
Researchers compared the outcome after hematopoietic stem cell transplantation of adolescents, aged 14-18 years, with that of children (i.e. patients younger than 14 years). [Blood] Abstract


High Concordance of Subtypes of Childhood Acute Lymphoblastic Leukemia within Families: Lessons from Sibships with Multiple Cases of Leukemia
Data indicate strong genetic and/or environmental risk factors for childhood acute lymphoblastic leukemia (ALL) that are restricted to specific ALL subtypes, which must be taken into account, when performing epidemiological studies to reveal etiological factors. [Leukemia] Abstract


Phase I Study of Topotecan, Ifosfamide, and Etoposide with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates
The purpose of this study is to determine the maximum tolerated dose of topotecan in combination with ifosfamide, mesna, and etoposide, followed by autologous hematopoietic cell transplant, in patients with chemotherapy-refractory malignancies. [Clin Cancer Res] Abstract


ON164-STEMSOFT_645x110
INDUSTRY NEWS
Abbott’s Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Abbott announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia. [Abbott Laboratories] Press Release


Babraham Announced as Partner in €30 Million European Project to Decipher the Epigenome
Researchers from the Babraham Institute’s Epigenetics Laboratories are partners in an exciting new initiative, launched this month by the health-research division of the European Commission with an investment of €30-million. [Babraham Institute] Press Release


CaridianBCT and Terumo Transfusion Unveil New Milestones in Progress Toward Becoming Terumo BCT at AABB Annual Meeting & CTTXPO 2011
CaridianBCT and Terumo Transfusion unveiled that they are uniting to become Terumo BCT, the world leader in blood component technology, products and services in the blood banking, transfusion medicine and cell therapy industries. [BusinessWire] Press Release
POLICY NEWS
Center for Scientific Review Notice of Closed Meetings (FR Doc No: 2011-27077) [National Institutes of Health, United States]

National Institutes of Health (United States)

Food and Drug Administration (United States)
 
Center for Biologics Evaluation and Research (United States)
 
European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
EVENTS
NEW Stem Cell Society Singapore Symposium 2011
November 17-18, 2011
Singapore, Singapore

Visit our events page to see a complete list of events in the hematopoietic community
JOB OPPORTUNITIES

Lab Technologist – Tissue Culture (STEMCELL Technologies)

Research and Development Technologist, hPSC Media (STEMCELL Technologies)

Scientist (iPSC) (STEMCELL Technologies)

Contract Assay Service Technologist (STEMCELL Technologies)

Lab Technologist – Pluripotent Stem Cells (STEMCELL Technologies)

Quality Control Technologist – Cell Separation (STEMCELL Technologies)

Scientist – Pluripotent Stem Cells (STEMCELL Technologies)

Postdoctoral Position – Regulation of Hematopoiesis by Extrinsic Regulators (Stem Cell Center Lund University)

Postdoctoral Fellow – Hematopoietic Stem Cells (City of Hope)

Postdoctoral Fellows – Blood Systems Research Institute (University of California, San Francisco)

Recruit Top Talent

Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe,
Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Hematopoiesis News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Hematopoiesis Cell News: Archives | Events | Contact Us